Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Jevon Martin, CEO of Princess Janae Place, addresses the challenges facing trans people—including COVID-19.
The assurance arrives as the pharma giant cuts off most emergency access to remdesivir, a potential COVID-19 treatment.
Gilead Sciences is giving its antiviral remdesivir to nearly 1,000 people as part of two clinical trials.
Over 60 drugmakers raised prices an average of 5.8% on hundreds of drugs.
Three fatty liver disease candidates miss the mark for effectiveness or safety.
The funding arrives via Gilead Sciences’ COMPASS Initiative.
The U.S. Health Department launched Ready, Set, PrEP to provide the HIV prevention med at no cost.
The pop star’s party is named after the HIV prevention drug and is meant as an homage to ’80s-era queer nightlife.
Is generic PrEP in 2020 too good to be true?
This will provide free PrEP to as many as 200,000 uninsured Americans until 2030.
A look at the supply chain that results in very high costs for HIV and hepatitis C medications.
With funding by the three coordinating centers of the Gilead COMPASS Initiative
Pre-exposure prophylaxis for those who have no health insurance
Located at the Rush Center, the SPOT builds upon the knowledge of people living with HIV.
Why aren’t the very young people whom Truvada as pre-exposure prophylaxis would help the most using this HIV prevention pill?
Three “high-profile advocates” share candid tales as part of Gilead’s video series to prevent HIV and STIs.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.